Overview

Study Using Pregnenolone to Treat Bipolar Depression

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
Primary purpose of this study is to determine if pregnenolone supplementation is associated with greater improvement in depressive symptoms of patients with bipolar disorder. Also the study will explore possibilities of improving anxiety and manic symptoms as well as the patient's cognition.
Phase:
Phase 4
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
Stanley Medical Research Institute